JGC
PGNX

J. Goldman & Co’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

J. Goldman & Co’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-499,698
Closed -$2.53M – 283
2019
Q3 		$2.53M Buy
499,698
+99,698
+25% +$504K 0.19% 82
2019
Q2 		$2.47M Buy
+400,000
New +$2.47M 0.17% 84